The Skinny Shot (Lipo-C Blend)
Also Known As: MIC blend, Lipotropic injection, Methionine Inositol Choline injection, Lipotropic cocktail, MIC injection, LIPO-C injection, Slim shot, Weight loss injection blend, Fat burner injection, Methionine inositol choline carnitine, Lipotropic weight management, Liver detox injection, B12 lipotropic blend, lipotropic, methionine inositol choline
The Skinny Shot (Lipo-C Blend) is a research-grade Lipotropic injection blend targeting Hepatic lipid metabolism studied in Weight Loss & Metabolism research. It is supplied strictly for in vitro laboratory research use only - not for human or animal consumption, and not FDA-approved.
Evidence Tier: Research Compound - No approved human use; sold for laboratory research only.
A compounded lipotropic injection marketed for weight support; weak controlled evidence.
At A Glance
| Category | Weight Loss & Metabolism |
|---|---|
| Compound Class | Lipotropic injection blend (Methionine + Inositol + Choline +/- Carnitine/B12) |
| Molecular Target | Hepatic lipid metabolism; choline as phosphatidylcholine precursor; methionine as methyl donor; inositol as PI3K second messenger |
| Molecular Weight | mixture |
| Amino Acid Sequence | Methionine + Inositol + Choline + B vitamins |
| CAS Number | n/a |
| Half-Life | ~2-4 hours (Lipotropic blend) |
| WADA Status | not_listed |
| Evidence Tier | Research Compound |
Mechanism Of Action
It delivers highly bioavailable lipotropic agents (Methionine, Inositol, Choline) that specifically help the liver break down and export fat, preventing fat buildup and speeding up metabolism.
Studied For
- Weight-management adjunct
- Fat metabolism support
- Liver lipid export
- Hepatic steatosis research
- Methyl donor support
- Choline-deficiency liver research
- Inositol insulin sensitization
- Carnitine fat oxidation adjunct
- Energy metabolism enhancement
- Detoxification support
- Body composition research
- Obesity adjunct therapy
- fat burning
- liver detox
- weight loss
- energy boost
- metabolism
Reported Research Findings
Benefit claims are predominantly anecdotal and clinic-marketed; controlled evidence that the injectable blend independently causes meaningful fat loss is weak.
Safety And Handling Notes
Injection-site reactions, transient GI upset, rare hypersensitivity; generally low risk at typical compounded amounts.
Not FDA-approved; a pharmacy-compounded preparation whose content varies; fat-loss efficacy is not established by controlled trials.
Regulatory Status
Not FDA-approved; pharmacy-compounded.
Full Reference Detail
Related Research Guides
Maintained By The Pep Nation Lab Research Team. See Our Editorial Standards And Research Methodology For How This Reference Is Sourced And Reviewed.
This Reference Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption. See The Full Research Disclaimer.